Gutscheinbedingungen

**Gültig bis 06.07.2026 auf fremdsprachige Bücher online auf thalia.at, in der Thalia App ab einem Mindestbestellwert von 30€ und in allen Thalia Buchhandlungen in Österreich. In den Buchhandlungen nur gültig auf lagernde Ware. Einzelne Artikel können ausgeschlossen sein. Ausgenommen sind preisgebundene Artikel & eBooks. Pro Einkauf einmal einlösbar. Nur gültig gegen Vorlage oder im Onlineshop hinterlegter Bonuscard. Infos zur Einlösung in der Buchhandlung sind auf der Bonuscard-Vorteilspreisseite zu finden. Click & Collect nur bei Onlinevorabzahlung möglich. Keine Einlösung bei Scan & Go-Bezahlung. Keine Barauszahlung. Nicht kombinierbar mit anderen Aktionen und Gutscheinen. Gutschein wird auf max. 500€ Bestellwert angerechnet. Nicht gültig für Versandkosten und Services.

Produktbild: Site Specific and Global Epigenomic Editing
Vorbesteller Neu

Site Specific and Global Epigenomic Editing Principles and Applications

237,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.06.2027

Herausgeber

Feng C. Zhou

Verlag

Elsevier

Seitenzahl

704

Maße (L/B)

23,5/19,1 cm

Sprache

Englisch

ISBN

978-0-12-819398-3

Beschreibung

Portrait

Dr. Feng C. Zhou is Professor Emertus of Anatomy and Cell Biology at Indiana University School of Medicine, Indianapolis, Indiana. In his research, Dr. Zhou studies genetic contributions to gene expression that underpin the neurochemical and neuroanatomical differences contributing to alcohol addiction. His previous research has demonstrated that alcohol alters expression cohorts of neural specification genes, and cell cycling genes in the canonical developmental pathways. In recent years, Dr. Zhou has expanded his research to include the genomics and epigenetics of alcoholism, epigenetic editing by optogenetics, cell-wide DNA de-methylation and re-methylation of purkinje neurons in the developing cerebellum, and environmental alterations of epigenetics prior to the birth, among other topics. Dr. Zhou has published widely in scientific, peer reviewed journals including Scientific Reports, PLoS ONE, Oncotarget, Frontiers in Genetics, Brain Research, Cell Transplantation, and Alcohol.

Dr. Tollefsbol is a Distinguished Professor of Biology and a Senior Scientist in the O’Neal Comprehensive Cancer Center, Integrative Center for Aging Research, Nutrition Obesity Research Center, University Wide Microbiome Center, and the Comprehensive Diabetes Center at the University of Alabama at Birmingham (UAB). He is Director of the UAB Cell Senescence Culture Facility which he established in 1999. Dr. Tollefsbol trained as a Postdoctoral Fellow and Assistant Research Professor with members of the National Academy of Science at Duke University and the University of North Carolina. He earned doctorates in molecular biology and osteopathic medicine from the University of North Texas Health Sciences Center and his bachelor’s degree in Biology from the University of Houston. He has received prior funding from the NCI, NHLBI, NIMH and other federal institutes as well as the Glenn Foundation for Medical Research, Susan G. Komen for the Cure, the American Federation for Aging Research (AFAR), and the American Institute for Cancer Research (AICR) among many other sources.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.06.2027

Herausgeber

Feng C. Zhou

Verlag

Elsevier

Seitenzahl

704

Maße (L/B)

23,5/19,1 cm

Sprache

Englisch

ISBN

978-0-12-819398-3

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Site Specific and Global Epigenomic Editing
  • Part I EPIGENETICS AND EPIGENOMICS
    1. Epigenetic editing: Progress and Challenges
    2. Epigenetic dynamics: Normal progression and abnormal alteration
    3. Epigenomic landscape
    4. Histone coding and its compounding influence on gene expression
    5. microRNA as a tool for gene regulation
    6. RNA editing and genetic influence
    7. Epitranscription: Scope and engineering ability

    Part II GLOBAL EPIGENETIC EDITING
    8. Global epigenetic editing uses methods of DNA methylation alteration drugs
    9. Regulating DNA methylation for developmental disorders
    10. Histone modification drug the HDACi: Selectivity and promise
    11. Histone modification in cancer treatment
    12. Alteration of DNA Methylation in gastric cancer
    13. Epigenetic therapy for the treatment of epithelial ovarian cancer
    14. Epigenetic application on allergy treatment
    15. HDACi therapy for the treatment of depression
    16. Histone modification on neurodevelopmental and neuropsychiatric disorders
    17. Epigenetics and Addiction
    18. Epigenetic Treatment of Persistent Viral Infections
    19. MicroRNA as strategy of gene regulation

    Part III SITE SPECIFIC EPIGENETIC EDITING
    20. Strategy and Molecular tools for site-specific editing
    21. Site-specific recruitment of epigenetic factors for spatio-temporal epigenetic editing.
    22. Monitoring CRISPR-Cas9 mediated DNA-methylation-editing
    23. Locus-specific editing of histone modifications
    24. Functional DNA methylation and epigenetic editing on proneuron genes during neuroglial differentiation
    25. Epigenetic editing through regulating CRISPR-Cas9 mediated non-coding RNA
    26. Epigenetic editing targeting a parkinsonian gene 
    27. Cancer gene epigenetic editing
    28. Epigenetic editing to unveil epigenetic mechanism of breast cancer
    29. Editing DNA Methylation on Fragile X syndrome
    30. Can RNA editing be engineered?
    31. Genetic and epigenetic interactive approaches

    Part IV TRANSLATIONAL AND CLINIC APPLICATION
    32. Tuning DNA methylation in treating breast cancer:
    33. Imminent Epigenetic editing in cancer treatment
    34. Epigenetic editing for developmental disorders
    35. Epigenetic editing on genetic imprinting
    36. Prospective epigenetic treatment on Neurological disease
    37. Epigenetic alterations and personalized treatment in cancer

    Part V CLOSING VIEW
    38. Obstacles and prospective of changing epigenetic codes
    39. Ethical matters in modification of epigenetic codes
    40. Future epigenetic treatment